PPAR’s as Critical Regulators of Metabolism

Prof Roden, Germany explains why PPAR’s are interesting therapeutic targets not only to improve adipose tissue function but also for the liver. The approach can go beyond the improvement of liver function and aim at a more systemic approach with cardiovascular benefits.

Prof. Michael Roden
November 11, 2020
Management, Nash Treatment, PPAR Agonists

Prof. Michael Roden

Video PPAR’s as Critical Regulators of Metabolism -Copyright ©2022 by PanNash™ Initiative - All rights reserved.

The slide above illustrates the role of PPARα, PPARβ/δ and PPARγ as key regulators of lipid metabolism, inflammation and glucose metabolism. Understanding the role of various peroxisome proliferator-activated receptors and their ligands in clinical practice is very important for the future of NASH management. It illustrates why a “pan” PPAR approach can be beneficial and why more research is needed.

Prof. Michael Roden
November 11, 2020
More Management, Nash Treatment, PPAR Agonists
ppars

Would you like to read more?

Prof. Michael Roden

Professor Dr. Michael Roden is Chair of Endocrinology and Metabolic Diseases, Heinrich-Heine University, Director of the Division of Endocrinology and Diabetology, University Clinics Düsseldorf and CEO of the German Diabetes Center (DDZ). He was trained at University of Vienna and Yale University. His translational studies..

Video SERIES

SUBSCRIBE & FOLLOW US

Subscribe Our Newsletter To Get the Lastest Updates